<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font14" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font15" size="7" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font17" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font18" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font19" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font21" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font22" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t2" reading_order_no="51" segment_no="23" tag_type="text">Page 1 of 7<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="52" segment_no="24" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="258" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">BMC Pharmacology</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="86" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research article<b>BMC Pharmacology</b></text>
<text top="105" left="55" width="499" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Tetrandrine and thapsigargin release arachidonic acid from cells in<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="498" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">culture and stimulate prostacyclin production in rat liver cells, but</text>
<text top="141" left="55" width="240" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title">may do so by different pathways<b>Tetrandrine and thapsigargin release arachidonic acid from cells in </b></text>
<text top="158" left="55" width="115" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Lawrence Levine*<b>culture and stimulate prostacyclin production in rat liver cells, but </b></text>
<text top="194" left="55" width="297" height="8" font="font11" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Address: Department of Biochemistry, Brandeis University, Waltham, MA 02454, USA<b>may do so by different pathways</b></text>
<text top="208" left="55" width="168" height="8" font="font11" id="p1_t12" reading_order_no="9" segment_no="7" tag_type="text">Email: Lawrence Levine* - llevine@brandeis.edu</text>
<text top="220" left="55" width="92" height="8" font="font11" id="p1_t13" reading_order_no="10" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="368" left="112" width="44" height="10" font="font12" id="p1_t14" reading_order_no="20" segment_no="16" tag_type="title">Abstract</text>
<text top="383" left="112" width="385" height="9" font="font13" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">Background: Tetrandrine inhibits tumor cell proliferation and demonstrates chemoprevention in<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15978132">  </a></text>
<text top="394" left="112" width="385" height="9" font="font14" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">cancer models. Speculation on the association between its effects on K + and Ca 2+ channels and<b>Abstract</b></text>
<text top="406" left="112" width="385" height="9" font="font14" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">cancer chemoprevention has been made. Thapsigargin also affects K + and Ca 2+ conductance.<b>Background: </b></text>
<text top="418" left="112" width="386" height="9" font="font14" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">Thapsigargin, however, is a weak tumor promoter in the two-stage model of mouse skin</text>
<text top="430" left="112" width="386" height="9" font="font14" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">carcinogenesis, yet it can induce apoptosis in androgen-independent prostatic cancer cells. I have</text>
<text top="441" left="112" width="386" height="9" font="font14" id="p1_t20" reading_order_no="26" segment_no="17" tag_type="text">postulated that arachidonic acid release from cells in culture is associated with cancer</text>
<text top="453" left="112" width="386" height="9" font="font14" id="p1_t21" reading_order_no="27" segment_no="17" tag_type="text">chemoprevention. The effects of tetrandrine and thapsigargin on arachidonic acid release from</text>
<text top="465" left="112" width="386" height="9" font="font14" id="p1_t22" reading_order_no="28" segment_no="17" tag_type="text">human colon carcinoma and rat liver cells and prostacyclin production by rat liver cells are</text>
<text top="477" left="112" width="129" height="9" font="font14" id="p1_t23" reading_order_no="29" segment_no="17" tag_type="text">compared in the current studies.</text>
<text top="493" left="112" width="385" height="9" font="font13" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">Results: Tetrandrine and thapsigargin stimulate arachidonic acid release from human colon</text>
<text top="505" left="112" width="386" height="9" font="font14" id="p1_t25" reading_order_no="31" segment_no="18" tag_type="text">carcinoma and rat liver cells and prostacyclin production in rat liver cells. The stimulation by</text>
<text top="517" left="112" width="386" height="10" font="font14" id="p1_t26" reading_order_no="32" segment_no="18" tag_type="text">tetrandrine is not affected by incubation with actinomycin D, 100 mM KCl, the [Ca 2+ ] i chelator, 1,2-</text>
<text top="529" left="112" width="385" height="9" font="font16" id="p1_t27" reading_order_no="33" segment_no="18" tag_type="text">bi s ( o -amino-5-fluorophenoxy) ethane- N,N,N',N' ,-tetraacetic acid tetraacetoxymethylester</text>
<text top="540" left="112" width="385" height="9" font="font14" id="p1_t28" reading_order_no="34" segment_no="18" tag_type="text">(BAPTA/AM) or in the absence of extracellular Ca 2+ . In contrast, stimulation by thapsigargin is</text>
<text top="552" left="112" width="386" height="9" font="font14" id="p1_t29" reading_order_no="35" segment_no="18" tag_type="text">inhibited by incubation with actinomycin D, 100  mM  KCl,  BAPTA/AM  or  in  the  absence  of</text>
<text top="564" left="112" width="72" height="9" font="font14" id="p1_t30" reading_order_no="36" segment_no="18" tag_type="text">extracellular Ca 2+ .</text>
<text top="581" left="112" width="385" height="9" font="font13" id="p1_t31" reading_order_no="37" segment_no="19" tag_type="text">Conclusion: Both tetrandrine and thapsigargin stimulate arachidonic acid release, but based on</text>
<text top="592" left="112" width="385" height="11" font="font14" id="p1_t32" reading_order_no="38" segment_no="19" tag_type="text">the different results obtained in the presence of actinomycin D, the [Ca 2+ ] i chelator, 100 mM KCl</text>
<text top="604" left="112" width="386" height="9" font="font14" id="p1_t33" reading_order_no="39" segment_no="19" tag_type="text">and in the absence of extracellular Ca 2+ , the mechanisms leading to this release and pathways</text>
<text top="616" left="112" width="386" height="9" font="font14" id="p1_t34" reading_order_no="40" segment_no="19" tag_type="text">leading to apoptosis and/or cancer chemoprevention may be different. Stimulations by tetrandrine</text>
<text top="628" left="112" width="385" height="10" font="font14" id="p1_t35" reading_order_no="41" segment_no="19" tag_type="text">may be mediated by activation of a secretory phospholipase A 2 , whereas thapsigargin's stimulations<b>Results: </b></text>
<text top="639" left="112" width="282" height="11" font="font14" id="p1_t36" reading_order_no="42" segment_no="19" tag_type="text">may be mediated by the cytoplasmic Ca 2+ -dependent phospholipase A 2 .</text>
<text top="689" left="55" width="60" height="10" font="font12" id="p1_t37" reading_order_no="43" segment_no="21" tag_type="title">Background</text>
<text top="700" left="55" width="241" height="9" font="font17" id="p1_t38" reading_order_no="44" segment_no="22" tag_type="text">Tetrandrine (TET), a bisbenzylisoquinoline (Fig. 1a), iso-</text>
<text top="712" left="55" width="241" height="9" font="font17" id="p1_t39" reading_order_no="45" segment_no="22" tag_type="text">lated from the root of the plant Stephania tetrandra has a</text>
<text top="724" left="55" width="241" height="9" font="font17" id="p1_t40" reading_order_no="46" segment_no="22" tag_type="text">number of potential medicinal properties. These include</text>
<text top="688" left="313" width="241" height="10" font="font17" id="p1_t41" reading_order_no="47" segment_no="20" tag_type="text">blockage of voltage-gated Ca 2+ channels [1], large-con-</text>
<text top="700" left="313" width="241" height="9" font="font17" id="p1_t42" reading_order_no="48" segment_no="20" tag_type="text">ductance Ca 2+ activated K + (BK) channels, and intracellu-</text>
<text top="712" left="313" width="241" height="9" font="font17" id="p1_t43" reading_order_no="49" segment_no="20" tag_type="text">lar Ca 2+ pumps [1-6]. TET also has anti-inflammatory<i>bi</i></text>
<text top="724" left="313" width="241" height="9" font="font17" id="p1_t44" reading_order_no="50" segment_no="20" tag_type="text">[2,7] and anti-cancer activities [8,9]. TET stimulates</text>
<text top="262" left="55" width="77" height="7" font="font20" id="p1_t45" reading_order_no="11" segment_no="9" tag_type="text">Published: 24 June 2005<i>o</i></text>
<text top="277" left="55" width="95" height="7" font="font21" id="p1_t46" reading_order_no="12" segment_no="12" tag_type="text">BMC Pharmacology 2005, 5 :12</text>
<text top="277" left="159" width="92" height="7" font="font20" id="p1_t47" reading_order_no="13" segment_no="12" tag_type="text">doi:10.1186/1471-2210-5-12<i>N,N,N',N'</i></text>
<text top="262" left="310" width="85" height="7" font="font20" id="p1_t48" reading_order_no="18" segment_no="10" tag_type="text">Received: 26 January 2005</text>
<text top="272" left="310" width="77" height="7" font="font20" id="p1_t49" reading_order_no="19" segment_no="11" tag_type="text">Accepted: 24 June 2005</text>
<text top="291" left="55" width="248" height="7" font="font20" id="p1_t50" reading_order_no="14" segment_no="13" tag_type="text">This article is available from: http://www.biomedcentral.com/1471-2210/5/12</text>
<text top="305" left="55" width="147" height="7" font="font20" id="p1_t51" reading_order_no="15" segment_no="14" tag_type="text">© 2005 Levine; licensee BioMed Central Ltd.</text>
<text top="315" left="55" width="492" height="7" font="font20" id="p1_t52" reading_order_no="16" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),<i>is</i></text>
<text top="324" left="55" width="400" height="7" font="font20" id="p1_t53" reading_order_no="17" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
